IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

January 9, 2024

https://www.globenewswire.com/news-release/2024/01/09/2806292/32443/en/IRADIMED-CORPORATION-Reports-Unaudited-Fourth-Quarter-and-2023-Revenue.html

WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) —  IRADIMED CORPORATION (the “Company”) (NASDAQ:IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023. The fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% from the prior year.

Read more at globenewswire.com

Related news for (IRMD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.